Cargando…

Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients

BACKGROUND: Epidermolysis bullosa acquisita (EBA) is an orphan autoimmune disease. Several clinical phenotypes have been described, but subepidermal blistering is characteristic of all variants. Limited data on clinical and immunopathological characteristics and treatment outcomes in EBA are availab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwata, Hiroaki, Vorobyev, Artem, Koga, Hiroshi, Recke, Andreas, Zillikens, Detlef, Prost-Squarcioni, Catherine, Ishii, Norito, Hashimoto, Takashi, Ludwig, Ralf J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122731/ https://www.ncbi.nlm.nih.gov/pubmed/30180870 http://dx.doi.org/10.1186/s13023-018-0896-1

Ejemplares similares

Epidermolysis Bullosa Acquisita: The 2019 Update
por: Koga, Hiroshi, et al.
Publicado: (2019)

Diagnosis of Epidermolysis Bullosa Acquisita: Multicentre Comparison of Different Assays for Serum Anti-type VII Collagen Reactivity
por: HOLTSCHE, Maike Marleen, et al.
Publicado: (2021)

Epidermolysis bullosa acquisita()
por: Miyamoto, Denise, et al.
Publicado: (2022)

Metabolite analysis distinguishes between mice with epidermolysis bullosa acquisita and healthy mice
por: Schönig, Sarah, et al.
Publicado: (2013)

Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita
por: Koga, Hiroshi, et al.
Publicado: (2018)

Pathological Relevance of Anti-Hsp70 IgG Autoantibodies in Epidermolysis Bullosa Acquisita
por: Tukaj, Stefan, et al.
Publicado: (2022)

T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita
por: Bieber, Katja, et al.
Publicado: (2016)

Clinical Presentation, Pathogenesis, Diagnosis, and Treatment of Epidermolysis Bullosa Acquisita
por: Ludwig, Ralf J.
Publicado: (2013)

Preventive but Not Therapeutic Topical Application of Local Anesthetics Can Inhibit Experimental Epidermolysis Bullosa Acquisita in Mice
por: Wen, Lifang, et al.
Publicado: (2021)

Epidermolysis bullosa acquisita: current diagnosis and therapy
por: Mehren, Christine R., et al.
Publicado: (2011)

Epidermolysis Bullosa Acquisita: A Case Report
por: Kumetz, Erik A., et al.
Publicado: (2020)

Epidermolysis Bullosa Acquisita—Current and Emerging Treatments
por: Tešanović Perković, Deša, et al.
Publicado: (2023)

Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita
por: Samavedam, Unni K., et al.
Publicado: (2018)

Risk factors and sequelae of epidermolysis bullosa acquisita: A propensity-matched global study in 1,344 patients
por: Kridin, Khalaf, et al.
Publicado: (2023)

C-type lectin receptor expression is a hallmark of neutrophils infiltrating the skin in epidermolysis bullosa acquisita
por: Guerrero-Juarez, Christian F., et al.
Publicado: (2023)

Epidermolysis bullosa acquisita: an uncommon cause of esophageal stricture
por: Figueredo, Carlos, et al.
Publicado: (2021)

Epidermolysis Bullosa Acquisita: A Report of Four Cases
por: De, Abhishek, et al.
Publicado: (2022)

Cytoskeletal Regulation of Inflammation and Its Impact on Skin Blistering Disease Epidermolysis Bullosa Acquisita
por: Kopecki, Zlatko, et al.
Publicado: (2016)

Therapeutic effects of Fc gamma RIV inhibition are mediated by selectively blocking immune complex-induced neutrophil activation in epidermolysis bullosa acquisita
por: Haeger, Swantje C., et al.
Publicado: (2022)

Case report: A case of epidermolysis bullosa acquisita with IgG and IgM anti-basement membrane zone antibodies relapsed after COVID-19 mRNA vaccination
por: Minakawa, Satoko, et al.
Publicado: (2023)

Acute renal failure in a patient with epidermolysis bullosa acquisita
por: Zhao, Guowei, et al.
Publicado: (2017)

Epidermolysis bullosa acquisita treated with ustekinumab: A case report
por: Prosty, Connor, et al.
Publicado: (2022)

Childhood Epidermolysis Bullosa Acquisita: Confirmation of Diagnosis by Skin Deficient in Type VII Collagen, Enzyme-linked Immunosorbent Assay, and Immunoblotting
por: Goyal, Nupur, et al.
Publicado: (2016)

EPIDERMOLYSIS BULLOSA ACQUISITA WITH MODERATELY SEVERE DYSPHAGIA DUE TO ESOPHAGEAL STRICTURES
por: Tu, Jenny, et al.
Publicado: (2011)

An atypical case of pediatric epidermolysis bullosa acquisita: Review of diagnosis and pitfalls
por: Patel, Ashaki, et al.
Publicado: (2021)

The development of mucous membrane epidermolysis bullosa acquisita in a pediatric patient
por: Rentfro, Kathryn, et al.
Publicado: (2021)

Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita
por: Kovacs, Balint, et al.
Publicado: (2020)

Persistent Autoantibody-Production by Intermediates between Short-and Long-Lived Plasma Cells in Inflamed Lymph Nodes of Experimental Epidermolysis Bullosa Acquisita
por: Tiburzy, Benjamin, et al.
Publicado: (2013)

Case Report: Diagnostic and Therapeutic Challenges in Severe Mechanobullous Epidermolysis Bullosa Acquisita
por: Schauer, Franziska, et al.
Publicado: (2022)

Treatment with anti‐neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in mice
por: Kasprick, Anika, et al.
Publicado: (2020)

Porphyria Cutanea Tarda Masquerading as Epidermolysis Bullosa Acquisita: A Report of Two Cases
por: Deen, Kristyn, et al.
Publicado: (2015)

Epidermolysis bullosa acquisita as an adverse effect from rituximab therapy: A case report
por: Wu, Xueqiong, et al.
Publicado: (2020)

Mycophenolate mofetil (MMF) in the treatment of epidermolysis bullosa acquisita (EBA) long-term follow-up
por: Sami, Naveed
Publicado: (2015)

The Syk Tyrosine Kinase Is Required for Skin Inflammation in an In Vivo Mouse Model of Epidermolysis Bullosa Acquisita
por: Németh, Tamás, et al.
Publicado: (2017)

Refractory Epidermolysis Bullosa Acquisita with Chronic Graft-versus-Host Disease Successfully Treated with Rituximab
por: Han, Ju Hee, et al.
Publicado: (2023)

Case Report: Biological treatment of epidermolysis bullosa acquisita: report on four cases and literature review
por: Szymański, Konrad, et al.
Publicado: (2023)

Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita
por: Zillikens, Hannah, et al.
Publicado: (2021)

Accessible Diagnostic Methods to Differentiate between Epidermolysis Bullosa Acquisita and Other Subepidermal Autoimmune Bullous Diseases
por: Kridin, Khalaf
Publicado: (2018)

Epidermolysis Bullosa Acquisita: A Case Report of a Rare Clinical Phenotype and a Review of Literature
por: Beiu, Cristina, et al.
Publicado: (2019)

Vesiculobullous Erythema Elevatum Diutinum: a Rare Variant With Epidermolysis Bullosa Acquisita-like Immunofluorescence Findings
por: Yalici-Armagan, Basak, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q6iohik55mpoqq4ri9jerv77ek